Intermittent Pressure Overload Triggers Hypertrophy-independent Cardiac Dysfunction and Vascular Rarefaction
Overview
Authors
Affiliations
For over a century, there has been intense debate as to the reason why some cardiac stresses are pathological and others are physiological. One long-standing theory is that physiological overloads such as exercise are intermittent, while pathological overloads such as hypertension are chronic. In this study, we hypothesized that the nature of the stress on the heart, rather than its duration, is the key determinant of the maladaptive phenotype. To test this, we applied intermittent pressure overload on the hearts of mice and tested the roles of duration and nature of the stress on the development of cardiac failure. Despite a mild hypertrophic response, preserved systolic function, and a favorable fetal gene expression profile, hearts exposed to intermittent pressure overload displayed pathological features. Importantly, intermittent pressure overload caused diastolic dysfunction, altered beta-adrenergic receptor (betaAR) function, and vascular rarefaction before the development of cardiac hypertrophy, which were largely normalized by preventing the recruitment of PI3K by betaAR kinase 1 to ligand-activated receptors. Thus stress-induced activation of pathogenic signaling pathways, not the duration of stress or the hypertrophic growth per se, is the molecular trigger of cardiac dysfunction.
Regulatory effects of resveratrol on nitric oxide signaling in cardiovascular diseases.
Abolfazli S, Karav S, Johnston T, Sahebkar A Pharmacol Rep. 2025; .
PMID: 39832074 DOI: 10.1007/s43440-025-00694-w.
Jean-Charles P, Roy B, Yu S, Pironti G, Nagi K, Mao L Am J Physiol Heart Circ Physiol. 2024; 327(5):H1257-H1271.
PMID: 39365672 PMC: 11559650. DOI: 10.1152/ajpheart.00329.2024.
Perez-Bonilla P, LaViolette B, Bhandary B, Ullas S, Chen X, Hirenallur-Shanthappa D PLoS One. 2024; 19(7):e0307467.
PMID: 39038017 PMC: 11262646. DOI: 10.1371/journal.pone.0307467.
Yanez-Bisbe L, Moya M, Rodriguez-Sinovas A, Ruiz-Meana M, Inserte J, Tajes M Int J Mol Sci. 2024; 25(3).
PMID: 38338818 PMC: 10855372. DOI: 10.3390/ijms25031541.
Treatment patterns and trajectories in patients after acute heart failure hospitalization.
Nakamaru R, Shiraishi Y, Kohno T, Nagatomo Y, Akiyama H, Motoya Y ESC Heart Fail. 2023; 11(2):692-701.
PMID: 38098210 PMC: 10966272. DOI: 10.1002/ehf2.14635.